Literature DB >> 16483723

Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase.

Z Xie1, W O Adamowicz, W D Eldred, A B Jakowski, R J Kleiman, D G Morton, D T Stephenson, C A Strick, R D Williams, F S Menniti.   

Abstract

PDE10A is a recently identified phosphodiesterase that is highly expressed by the GABAergic medium spiny projection neurons of the mammalian striatum. Inhibition of PDE10A results in striatal activation and behavioral suppression, suggesting that PDE10A inhibitors represent a novel class of antipsychotic agents. In the present studies we further elucidate the localization of this enzyme in striatum of rat and cynomolgus monkey. We find by confocal microscopy that PDE10A-like immunoreactivity is excluded from each class of striatal interneuron. Thus, the enzyme is restricted to the medium spiny neurons. Subcellular fractionation indicates that PDE10A is primarily membrane bound. The protein is present in the synaptosomal fraction but is separated from the postsynaptic density upon solubilization with 0.4% Triton X-100. Immuno-electron microscopy of striatum confirms that PDE10A is most often associated with membranes in dendrites and spines. Immuno-gold particles are observed on the edge of the postsynaptic density but not within this structure. Our studies indicate that PDE10A is associated with post-synaptic membranes of the medium spiny neurons, suggesting that the specialized compartmentation of PDE10A enables the regulation of intracellular signaling from glutamatergic and dopaminergic inputs to these neurons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16483723      PMCID: PMC1464838          DOI: 10.1016/j.neuroscience.2005.12.042

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  25 in total

1.  Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A).

Authors:  K Fujishige; J Kotera; H Michibata; K Yuasa; S Takebayashi; K Okumura; K Omori
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

2.  PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization.

Authors:  K Nakai; P Horton
Journal:  Trends Biochem Sci       Date:  1999-01       Impact factor: 13.807

3.  mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain.

Authors:  Wilma C G Van Staveren; Harry W M Steinbusch; Marjanne Markerink-Van Ittersum; David R Repaske; Michael F Goy; Jun Kotera; Kenji Omori; Joseph A Beavo; Jan De Vente
Journal:  J Comp Neurol       Date:  2003-12-22       Impact factor: 3.215

Review 4.  PDZ domain proteins of synapses.

Authors:  Eunjoon Kim; Morgan Sheng
Journal:  Nat Rev Neurosci       Date:  2004-10       Impact factor: 34.870

Review 5.  Striatal interneurones: chemical, physiological and morphological characterization.

Authors:  Y Kawaguchi; C J Wilson; S J Augood; P C Emson
Journal:  Trends Neurosci       Date:  1995-12       Impact factor: 13.837

Review 6.  Tailoring cAMP-signalling responses through isoform multiplicity.

Authors:  M D Houslay; G Milligan
Journal:  Trends Biochem Sci       Date:  1997-06       Impact factor: 13.807

Review 7.  Neostriatal cell subtypes and their functional roles.

Authors:  Y Kawaguchi
Journal:  Neurosci Res       Date:  1997-01       Impact factor: 3.304

8.  Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95.

Authors:  H C Kornau; L T Schenker; M B Kennedy; P H Seeburg
Journal:  Science       Date:  1995-09-22       Impact factor: 47.728

9.  A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain.

Authors:  D R Repaske; J G Corbin; M Conti; M F Goy
Journal:  Neuroscience       Date:  1993-10       Impact factor: 3.590

10.  Subcellular localization of cyclic nucleotide phosphodiesterase type 10A variants, and alteration of the localization by cAMP-dependent protein kinase-dependent phosphorylation.

Authors:  Jun Kotera; Takashi Sasaki; Tamaki Kobayashi; Kotomi Fujishige; Yoko Yamashita; Kenji Omori
Journal:  J Biol Chem       Date:  2003-11-06       Impact factor: 5.157

View more
  62 in total

1.  Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity.

Authors:  Ana Saavedra; Albert Giralt; Laura Rué; Xavier Xifró; Jian Xu; Zaira Ortega; José J Lucas; Paul J Lombroso; Jordi Alberch; Esther Pérez-Navarro
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

2.  Global Proteome and Ubiquitinome Changes in the Soluble and Insoluble Fractions of Q175 Huntington Mice Brains.

Authors:  Karen A Sap; Arzu Tugce Guler; Karel Bezstarosti; Aleksandra E Bury; Katrin Juenemann; Jeroen A A Demmers; Eric A Reits
Journal:  Mol Cell Proteomics       Date:  2019-05-28       Impact factor: 5.911

Review 3.  TAK-063, a novel PDE10A inhibitor with balanced activation of direct and indirect pathways, provides a unique opportunity for the treatment of schizophrenia.

Authors:  Kazunori Suzuki; Haruhide Kimura
Journal:  CNS Neurosci Ther       Date:  2018-01-09       Impact factor: 5.243

4.  Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation.

Authors:  Sarah Threlfell; Stephen Sammut; Frank S Menniti; Christopher J Schmidt; Anthony R West
Journal:  J Pharmacol Exp Ther       Date:  2008-12-04       Impact factor: 4.030

5.  In Vivo Characterization of Two 18F-Labeled PDE10A PET Radioligands in Nonhuman Primate Brains.

Authors:  Hui Liu; Hongjun Jin; Zonghua Luo; Xuyi Yue; Xiang Zhang; Hubert Flores; Yi Su; Joel S Perlmutter; Zhude Tu
Journal:  ACS Chem Neurosci       Date:  2018-02-19       Impact factor: 4.418

6.  FACS purification of immunolabeled cell types from adult rat brain.

Authors:  Danielle Guez-Barber; Sanya Fanous; Brandon K Harvey; Yongqing Zhang; Elin Lehrmann; Kevin G Becker; Marina R Picciotto; Bruce T Hope
Journal:  J Neurosci Methods       Date:  2011-09-03       Impact factor: 2.390

7.  Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum.

Authors:  Corina Russwurm; Doris Koesling; Michael Russwurm
Journal:  J Biol Chem       Date:  2015-03-11       Impact factor: 5.157

Review 8.  The role of phosphodiesterases in schizophrenia : therapeutic implications.

Authors:  Judith A Siuciak
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  RNA-Sequencing Analysis Revealed a Distinct Motor Cortex Transcriptome in Spontaneously Recovered Mice After Stroke.

Authors:  Masaki Ito; Markus Aswendt; Alex G Lee; Shunsuke Ishizaka; Zhijuan Cao; Eric H Wang; Sabrina L Levy; Daniel L Smerin; Jennifer A McNab; Michael Zeineh; Christoph Leuze; Maged Goubran; Michelle Y Cheng; Gary K Steinberg
Journal:  Stroke       Date:  2018-09       Impact factor: 7.914

10.  Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease.

Authors:  Carmela Giampà; Daunia Laurenti; Serenella Anzilotti; Giorgio Bernardi; Frank S Menniti; Francesca Romana Fusco
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.